https://www.selleckchem.com/products/h3b-120.html
UFH was significantly associated with reduced 28-day mortality (HR, 0.323, 95% CI, 0.258-0.406; p less then 0.001) and hospital mortality (HR, 0.380, 95% CI, 0.307-0.472; p less then 0.001) without increasing the risks of intracranial hemorrhage (OR, 1.480, 95% CI, 0.955-2.294; p = 0.08 or gastrointestinal bleeding (OR, 1.094, 95% CI, 0.503-2.382; p = 0.82. For subgroup analysis, it didn't change the favorable results of UFH on mortality and UFH didn't increase the risk of hemorrhage in patients with severe disease. Conclusions The
Like
Comment
Share
